EVP-6124 and the α7nAChR positive allosteric modulator AVL-3288 have been shown to be well tolerated in patients [104,105], but some concerns exist about effects of potentiation of α7nAChR mediated Ca2+ effects in AD. This evidence concerns the gene CHRNA7 and Alzheimer disease.